Skip to main content
The Journal of Immunology Author Choice logoLink to The Journal of Immunology Author Choice
. 2019 Nov 18;203(12):3179–3189. doi: 10.4049/jimmunol.1901072

CXCR3 Identifies Human Naive CD8+ T Cells with Enhanced Effector Differentiation Potential

Gabriele De Simone *, Emilia M C Mazza *, Antonino Cassotta †,, Alexey N Davydov §, Mirela Kuka , Veronica Zanon *, Federica De Paoli *, Eloise Scamardella *, Maria Metsger §, Alessandra Roberto *, Karolina Pilipow *, Federico S Colombo , Elena Tenedini #, Enrico Tagliafico #, Luca Gattinoni **,††, Domenico Mavilio ‡‡,§§, Clelia Peano ¶¶,‖‖, David A Price ##,***, Satya P Singh †††, Joshua M Farber †††, Valentina Serra ‡‡‡, Francesco Cucca ‡‡‡, Francesco Ferrari §§§, Valeria Orrù ‡‡‡, Edoardo Fiorillo ‡‡‡, Matteo Iannacone ¶,1, Dmitriy M Chudakov §,¶¶¶,‖‖‖,1, Federica Sallusto †,‡,1, Enrico Lugli *,‖,
PMCID: PMC6900484  PMID: 31740485

Key Points

  • CXCR3 identifies human naive CD8+ T cells with biased effector potential.

  • Human naive CD8+ T cell subsets are functionally and transcriptionally distinct.

  • Effector potential correlates with the physicochemical attributes of expressed TCRs.

Abstract

In mice, the ability of naive T (TN) cells to mount an effector response correlates with TCR sensitivity for self-derived Ags, which can be quantified indirectly by measuring surface expression levels of CD5. Equivalent findings have not been reported previously in humans. We identified two discrete subsets of human CD8+ TN cells, defined by the absence or presence of the chemokine receptor CXCR3. The more abundant CXCR3+ TN cell subset displayed an effector-like transcriptional profile and expressed TCRs with physicochemical characteristics indicative of enhanced interactions with peptide–HLA class I Ags. Moreover, CXCR3+ TN cells frequently produced IL-2 and TNF in response to nonspecific activation directly ex vivo and differentiated readily into Ag-specific effector cells in vitro. Comparative analyses further revealed that human CXCR3+ TN cells were transcriptionally equivalent to murine CXCR3+ TN cells, which expressed high levels of CD5. These findings provide support for the notion that effector differentiation is shaped by heterogeneity in the preimmune repertoire of human CD8+ T cells.

Introduction

Mature naive T (TN) cells are released from the thymus with predetermined specificities encoded by the somatically rearranged TCR. The human TN cell repertoire incorporates >108 different TCRs (1, 2), and a single TCR can recognize >106 different peptide Ags (3). This inherent cross-reactivity enables comprehensive recognition of exogenous Ags and ensures that TN cells can also interact with self-derived Ags (4). In mice, TCR interactions with self-derived peptide–MHC class I (pMHCI) complexes generate tonic signals, which do not induce effector responses in the absence of inflammation but are required for the survival of CD8+ TN cells in the periphery (5, 6). These signals also drive low-level homeostatic proliferation in conjunction with IL-7, which in turn maintains a diverse repertoire of clonotypically expressed TCRs in the CD8+ TN cell pool, even under conditions of reduced thymic output (4, 6).

In response to immune activation, TN cells differentiate into effector cells that migrate to peripheral tissues and eliminate the inciting Ag. Once this process is complete, small numbers of Ag-specific T cells survive and become long-lived memory T (TMEM) cells (7), which exhibit diverse epigenetic, functional, metabolic, and transcriptional properties (813). TN cells have long been considered largely homogenous at the population level (11, 1416). However, the recent application of emerging single-cell technologies has shown that individual clonotypes in the TN cell pool can behave very differently in response to Ag recognition via the TCR. For example, single-cell adoptive transfer and barcoding experiments in mouse challenge models have demonstrated that some CD8+ TN cells proliferate extensively and differentiate into effector cells, whereas other CD8+ TN cells proliferate to a lesser extent and differentiate into memory cells (17, 18). Another report described similar heterogeneity in the murine CD4+ TN cell pool and further suggested that individual cellular trajectories were determined primarily by Ag density and TCR dwell time (19). All of these studies concluded that classical T cell responses arise via population averaging rather than uniform behavior (1719).

In mice, the ability of TN cells to respond to exogenous Ags correlates with the level of cross-reactivity against self-derived Ags, which can be quantified via the surrogate marker CD5 (2022). Functionally distinct subsets of murine TN cells have also been identified on this basis. For example, CD8+ TN cells that express high levels of CD5 are hyperresponsive to the homeostatic cytokines IL-2 and IL-7 (23) and upregulate genes associated with effector differentiation (22), and CD4+ TN cells that express high levels of CD5 display enhanced signaling potency downstream of the TCR (20, 21). CD5 has been used as a proxy for similar purposes in phenotypic analyses of human CD8+ TN cells (24, 25), However, it remains unclear whether such functional heterogeneity exists among human CD8+ TN cells and, if so, to what extent it determines the efficacy of adaptive immune responses.

Materials and Methods

Study approvals

The use of human samples was approved by the relevant Institutional Review Boards. Ethical approval for the use of buffy coats was granted by the Humanitas Research Hospital and the Swiss Federal Office of Public Health (A000197/2). Ethical approval for the use of peripheral blood (PB) samples from the SardiNIA study was granted by the Consiglio Nazionale delle Ricerche (0078008/2017). Ethical approval for the use of lymph nodes (LNs) from patients with head and neck cancer was granted by the Humanitas Research Hospital (700/2010). Mouse protocols were approved by the Humanitas Institutional Animal Care and Use Committee and the Italian Ministry of Health (452/2018-PR).

Cells

PBMCs were isolated from buffy coats via standard density gradient centrifugation. In most assays, PBMCs were used immediately after isolation. In some assays, PBMCs were used after cryopreservation at −80°C in FBS containing 10% DMSO. Naive CD8+ T cells were enriched by magnetic separation using a MojoSort Human CD8+ Naive T Cell Isolation Kit (BioLegend), and total CD8+ T cells were enriched by magnetic separation using an EasySep Human CD8+ T Cell Isolation Kit (Stemcell Technologies).

Human tissue samples

LNs were surgically removed from patients with head and neck cancer (age, 31–69 y) and processed as described previously (26). Information on tissue samples from publicly available mass cytometry by time-of-flight (CyTOF) data reported in this study can be found in Supplemental Table II from Wong et al. (27).

Flow cytometry and cell sorting

Fluorochrome-conjugated mAbs were purchased from BD Biosciences, BioLegend, or eBioscience. All reagents were titrated before use to determine optimal concentrations (28, 29). Chemokine receptor expression was measured by incubating cells for 20 min at 37°C. Surface markers were measured by incubating cells for 20 min at room temperature. Intracellular effector molecules were revealed using a Cytofix/Cytoperm Kit (BD Biosciences). Dead cells were eliminated from the analysis using Zombie Aqua (BioLegend). Data were acquired using an LSRFortessa or a FACS Symphony A5 (BD Biosciences) and analyzed with FlowJo software version 9 (FlowJo). Naive CXCR3 (TNR3) and CXCR3+ (TNR3+) cells were flow-sorted using a FACSAria III (BD Biosciences). The gating strategy is depicted in Fig. 1A. Single-stained compensation controls were prepared using Ab-capture beads (BD Biosciences) as described previously (30).

FIGURE 1.

FIGURE 1.

CXCR3 identifies two subsets of TN cells in humans. (A) Representative flow cytometric analysis of CXCR3 expression on the surface of TN cells (CD45ROCCR7+CD27+CD95). Numbers indicate the percentage of cells in each gate. (B) Expression of CXCR3 relative to B2M mRNA in flow-sorted TNR3 and TNR3+ cells (n = 5). Each color indicates a different donor. Data are shown as mean ± SEM. n.d., not detected. (C) Frequency analysis of T cell subsets in PB samples from healthy individuals (n = 26). Data are shown as mean ± SEM. TSCM (CD45ROCCR7+CD27+CD95+); TCM, central TMEM (CD45RO+CCR7+); TEM, effector TMEM (CD45RO+CCR7); and TTE, terminal effector T (CD45ROCCR7) cells. (D) tSNE map displaying the surface immunophenotypes of circulating TNR3, TNR3+, and TMEM cells overlaid on the total CD8+ T cell population. Left, TNR3 (red); right, TNR3+ (blue). Data were obtained using CyTOF. Individual markers are shown in (E). (E) Heatmap showing percent expression of the indicated markers among CD8+ T cell subsets identified in PB. Data were obtained using CyTOF. Subsets were defined as in (C). (F) Frequency analysis of TNR3 and TNR3+ cells among total CD8+ T cells isolated from human tonsils (n = 5), spleen (n = 3), liver (n = 3), gut (n = 6), skin (n = 5), and lungs (n = 4). Data are shown as mean ± SEM. *p < 0.05 (paired t test). (G) Percent ratio of TNR3+/TNR3 cells in paired LN and PB samples. Data are shown as mean ± SEM. (H) Frequency analysis of circulating TNR3 and TNR3+ cells in 1938 individuals (age, 19–105 y). Red lines indicate linear regression. Effect size and p value are shown for each correlation.

Age-associated changes in TN cell subsets

TNR3 and TNR3+ cells were quantified in venous blood samples obtained from a cohort of 1938 individuals comprising 815 males and 1123 females (age, 19–105 y) enrolled via the SardiNIA study (31, 32). To avoid circadian fluctuations and time-dependent artifacts, all samples were collected in heparin tubes at 8 am, and immunophenotyping was performed within 2 h at the recruitment site. CXCR3 and CXCR3+ cells were quantified among naive-like CD8+ T cells, defined as CD3+CD4CD45RA+CCR7+CD127+CD161PD-1. Data were acquired using a FACSAria III.

Cell culture

Cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 1% penicillin/streptomycin, and 2 mM l-glutamine (R10). To induce cytokine production, flow-sorted TNR3 and TNR3+ cells were stimulated in a final volume of 200 μl with PMA (10 ng/ml; Sigma-Aldrich) and ionomycin (500 ng/ml; Sigma-Aldrich) for 6 h in the presence of GolgiPlug (1 μl/ml; BD Biosciences).

Quantification of TCR excision circles

TNR3, TNR3+, stem cell–like TMEM (TSCM), and bulk CD45RO+ TMEM cells were flow-sorted in PBS without Ca2+ and Mg2+, washed twice in the same buffer, and cryopreserved at −80°C. Thawed cells were lysed with proteinase K (100 μg/ml diluted in 10 mM Tris-HCl pH 8; 10 μl/100,000 cells; Roche). TCR rearrangement excision circles (TRECs) were measured using quantitative PCR (qPCR) as described previously (33) and normalized to the number of cells in each sample, determined via quantification of FAS.

Quantification of gene expression via qPCR

Total RNA was purified using an RNeasy Micro Kit with DNAse (Qiagen), reverse transcribed using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems), and analyzed using qPCR with hydrolysis probes for CXCR3 (Hs00171041_m1). Reactions were set up using TaqMan Universal PCR Master Mix, No Amperase UNG (Roche) in MicroAmp Fast Optical 96-Well Reaction Plates (Applied Biosystems) and processed using an ABI 7900HT Sequence Detection System (Applied Biosystems). Expression levels were normalized (Δcycle threshold [Ct]) to the reference gene B2M (Hs00187842_m1) using the equation 2− (Ct CXCR3 – Ct B2M).

HLA class I tetramers

Fluorochrome-conjugated tetrameric complexes of HLA-A*0201/CMV pp65495–503 NLVPMVATV (NV9), HLA-A*0201/influenza virus (Flu) matrix protein 1 (M1)58–66 GILGFVFTL (GL9), and HLA-A*0201/MART-126–35 ELAGIGILTV (EV10) were generated and used as described previously (34, 35). Data were acquired from a per sample average of 6 × 106 PBMCs.

Enumeration of Ag-specific TN cell precursors

Total CD8+ T cells and monocytes were isolated from PBMCs via positive selection using magnetic CD8 and CD14 MicroBeads, respectively (Miltenyi Biotec). Two subsets of CD4CD19CD56CD8+CD45RA+CCR7+CD27+CD95 naive cells were identified on the basis of CXCR3 expression among total CD8+ T cells and flow-sorted using a FACSAria III. CD8+ TMEM cells were flow-sorted in parallel as controls. Flow-sorted T cells were cultured in RPMI 1640 medium supplemented with 5% human serum (Swiss Red Cross), 1% (v/v) nonessential amino acids, 1% (v/v) sodium pyruvate, 50 U/ml penicillin, 50 μg/ml streptomycin, and 2 mM l-glutamine (all from Invitrogen). Amplified libraries were generated in 96-well plates (2000 cells per well) via polyclonal stimulation with PHA (1 μg/ml; Remel) in the presence of irradiated (45 Gy) allogeneic feeder cells (2.5 × 104 cells per well) and IL-2 (500 IU/ml) as described previously (36). Libraries were screened 14–21 d after stimulation by culturing thoroughly washed T cells (2.5 × 105 cells per well) with autologous irradiated B cells (2.5 × 104 cells per well) pulsed for 3 h with various Ags. The following Ags were used in these assays: a pool of 386 18-mer peptides spanning the entire 2004 consensus clade C HIV-1 proteome (1 μg/ml/peptide); a pool of 669 10-mer peptides spanning the Zika virus H/PF/2013 proteins Env, NS3, and NS5 (1 μg/ml/peptide); a pool of 198 8–11-mer peptides corresponding to immunogenic regions of CMV (1 μg/ml/peptide); a pool of 218 8–11-mer peptides corresponding to immunogenic regions of EBV (1 μg/ml/peptide); and a pool of 351 15-mer peptides spanning the Flu H1N1 strain A/California/07/2009 proteins hemagglutinin, M1, neuraminidase, and nucleoprotein (2 μg/ml/peptide). Proliferation was assessed on d 4 after incubation for 16 h with 1 μCi/ml [3H]thymidine (Perkin Elmer). Precursor frequencies were calculated based on the number of negative wells, assuming a Poisson distribution.

Ag-specific T cell proliferation and effector functions

Flow-sorted TNR3, TNR3+, and TMEM cells from CMV-seronegative donors were labeled with CFSE and cultured at a ratio of 2:1 with irradiated autologous monocytes pulsed for 5 h with a human CMV lysate or a seasonal Flu vaccine (Influvac 2017/2018; Mylan). The respective cultures were supplemented with pooled CMV peptides (1 μg/ml/peptide) or pooled Flu M1 peptides (2 μg/ml/peptide). On d 10, cells were stimulated with PMA and ionomycin for 5 h in the presence of brefeldin A for the final 2 h (all reagents from Sigma-Aldrich). Cell viability was determined using a LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Thermo Fisher Scientific). Intracellular effector molecules were identified by flow cytometry after fixation/permeabilization with Cytofix/Cytoperm.

TCR sequencing and data analysis

TNR3, TNR3+, and TMEM cells were flow-sorted in triplicate (300,000 cells per subset) directly into RLT buffer (1.2 ml; final dilution <20%; Qiagen). Total RNA was extracted using an RNeasy Mini Kit (Qiagen). Unique molecular identifier (UMI)-labeled 5′ RACE TRB cDNA libraries were prepared using a Human TCR Profiling Kit (MiLaboratory). All extracted RNA was used for cDNA synthesis, and all synthesized cDNA was used for PCR amplification. Libraries were prepared in parallel using the same number of PCR cycles and sequenced using a 150 + 150 bp approach on a NextSeq 500 (Illumina). Approximately 135 × 106 TRB reads were obtained in total (1.5 ± 0.3 × 106 reads per library), from which ∼4 × 106 unique UMI-labeled TRB cDNA molecules were extracted using MIGEC (37) and MiXCR (38) software (53,000 ± 10,000 molecules per library), with the MIGEC threshold set to at least two reads per UMI. Each library contained an average of 40,000 ± 10,000 functional (in-frame with no stop codons) CDR3 nucleotide sequence variants (unique TRB clonotypes). Averaged physicochemical characteristics of the 5 aa residues located in the middle of the TRB CDR3 sequence (weighted by clonotype size) were analyzed using VDJtools software (39). These characteristics included the estimated energy of the interaction between cognate peptide and the TRB CDR3 (40), the strength of this interaction as a derivative of energy, volume, and hydrophobicity (Kidera factor 4) (41, 42). Diversity metrics were analyzed using VDJtools after normalization to 5000 randomly selected UMI-labeled TRB cDNA molecules per sample.

DNA microarrays

Flow-sorted TNR3, TNR3+, and TMEM cells were washed twice in PBS without Ca2+ and Mg2+, resuspended in RLT buffer (Qiagen), and processed as described previously (43). Microarray probe fluorescence signals were converted to expression values using the robust multiarray average procedure in the Bioconductor Affy package (44). Log2 expression values for a total of 32,500 custom probe sets were calculated from background-adjusted and quantile-normalized fluorescence intensities using median polish summarization and custom chip definition files for the Affymetrix Human Transcriptome Array 2.0 based on Entrez genes (hta20_Hs_ENTREZG version 21.0.0). All data analyses were performed in R version 3.4.4. Differentially expressed genes (DEGs) were identified via paired comparisons of TNR3 and TNR3+ cells using the limma algorithm in the same R package (45).

Pathway analysis of microarray data

Mouse gene identifications obtained from comparisons between TNR3+ and CD5lo or CD5hi cells were converted into the corresponding human orthologous genes using the HUGO Gene Nomenclature Committee Database (https://www.genenames.org/cgi-bin/hcop). Pathway analysis was performed using gene set enrichment analysis (GSEA) software (http://software.broadinstitute.org/gsea/msigdb/) and gene sets from the Molecular Signatures Database (version 6.2). Specific gene sets included the c2 (c2.cp.reactome.v6.2) and immunological signatures collections (c7.all.v6.2). GSEA was applied to log2-transformed expression data obtained from TNR3 and TNR3+ cells. Gene sets were considered significantly enriched at false discovery rate (FDR) values ≤ 0.05 using Signal2Noise as a metric across 1000 permutations.

Mouse TN cell sorting and RNA sequencing

Spleens were obtained from 12-wk-old male C57BL/6 mice (Charles River Laboratories) and mechanically smashed through a cell strainer with a pore size of 40 μm. Splenocytes were enriched for CD8+ T cells using a MojoSort Mouse CD8+ T Cell Isolation Kit (BioLegend). Flow-sorted cells were lysed in RLT buffer (50 μl; Qiagen) containing RNAse Inhibitor (1 μl; Qiagen). Total RNA was extracted using an RNeasy Micro Kit (Qiagen). RNA sequencing (RNAseq) libraries were prepared using a SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (Takara Clontech). Libraries were pooled at equimolar concentrations and sequenced on a NextSeq 500 (Illumina). At least 20 × 106 single-end reads (75 bp) were generated per sample.

RNAseq data analysis

Raw sequence data were quality controlled using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Single-end reads (75 bp) were then aligned to the Mus musculus reference genome (Ensembl assembly GRCm38) using STAR (version 2.5.1b) (46). Alignments were performed using default parameters. Reads associated with annotated genes were counted using the HTSeq and “-quantmode TranscriptomeSAM GeneCounts” options. Differential gene expression between mouse TN subsets was assessed using the edgeR package (version 3.22) (47). Benjamini-Hochberg correction was applied to estimate the FDR.

t-distributed stochastic neighbor embedding analysis of high-dimensional CyTOF data

Public CyTOF data obtained from tonsils, spleen, liver, gut, skin, and lungs (27) were downloaded from https://flowrepository.org/. Debarcoded sample files were imported into FlowJo (version 9) and concatenated into a single.fcs file (∼2500 events per sample), which was then subjected to t-distributed stochastic neighbor embedding (tSNE) analysis (Barnes-Hut implementation) using the following parameters: iterations, 1000; perplexity, 40; initialization, deterministic; θ, 0.5; and η, 200. All markers listed in Fig. 1E were included in the analysis, except CXCR3.

Statistics

Statistical analyses were performed using GraphPad Prism version 7 or R software version 3.4.4. Significance was assigned at p < 0.05 unless stated otherwise. Specific tests are indicated in the figure legends for each comparison.

Data availability

Raw microarray and RNAseq data are available via the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) under accession number GSE125102. Demultiplexed fastq TCR sequencing data are available via the ArrayExpress Database at The European Molecular Biology Laboratory–European Bioinformatics Institute (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-7638.

Results

CXCR3 identifies two subsets of TN cells in humans

A previous flow cytometric analysis of human TN cell populations (9), identified using stringent phenotypic criteria (CD45ROCCR7+CD27+CD95) to exclude memory contaminants (48, 49), demonstrated that CXCR3 was not uniformly expressed by CD8+ TN cells. Instead, there was a clear bimodal distribution, which distinguished CXCR3 (TNR3) and CXCR3+ (TNR3+) cells (Fig. 1A). To confirm this finding, we flow-sorted TNR3 and TNR3+ cells and evaluated CXCR3 mRNA expression via qPCR. In accordance with the protein data, CXCR3 mRNA was readily detected in TNR3+ cells, but was uncommon in TNR3 cells (Fig. 1B). CXCR3 protein expression was detected at equivalent levels on the surface of CD8+ TN cells with two different anti-CXCR3 mAbs (Supplemental Fig. 1A). However, a partial loss of CXCR3 expression was observed after cryopreservation (Supplemental Fig. 1B), as noted previously (50). A vast majority of our assays were therefore performed using freshly isolated PBMCs.

We then quantified TN and TMEM cell subsets in the PB of healthy individuals and found that TNR3+ cells were ∼3-fold more abundant than TNR3 cells under physiological conditions (Fig. 1C). To gain further insights into the surface phenotype of these two subsets, we took advantage of a publicly available CyTOF data set reported by Wong et al. (27) who investigated the surface proteome of CD8+ T cells from various human tissues. Dimensionality reduction via tSNE revealed that TNR3 and TNR3+ cells from PB (Fig. 1D) and tissues (Supplemental Fig. 1C) mapped to similar regions of the plot, indicating a common phenotype, whereas both subsets were distinct from conventional CD45RO+ TMEM cells. A simultaneous analysis of surface markers involved in differentiation, homing, and activation/costimulation further revealed that TNR3 and TNR3+ cells shared phenotypic traits of TN cells, including the presence of CD45RA, CD27, CD62L, and CD127, and the absence of molecules such as CD49a, CD49d, CD57, CD95, CCR5, CLA, and PD-1 (Fig. 1E, Supplemental Fig. 1D) (11).

TN cells preferentially migrate to secondary lymphoid organs rather than mucosal tissues (51, 52). In line with this general dichotomy, TNR3 and TNR3+ cells were relatively abundant in human tonsils, less so in spleen and liver, and virtually undetectable in gut, skin, and lungs (Fig. 1F). On the basis of these data, it seems unlikely that CXCR3 regulates TN cell trafficking under physiological conditions. Moreover, we found very similar frequencies of TNR3 and TNR3+ cells in paired LN and PB samples (Fig. 1G), and CD8+ TN cells almost invariably lacked the tissue-residency markers CD69 and CD103, irrespective of anatomical localization and expression of CXCR3 (Supplemental Fig. 1D).

TN cells become less frequent with age (53). To investigate the impact of aging on TN cell subsets, we analyzed PB samples obtained from a previously reported cohort of 1938 healthy individuals, spanning an age range from 19 to 105 y (31, 32). We found that TNR3 and TNR3+ cells declined with age, but at slightly different rates, such that TNR3+ cells became progressively more common in the CD8+ TN cell pool (Fig. 1H).

True naivety of TNR3+ cells

Previous work identified CXCR3+ TN-like cells in the CD4+ lineage as memory precursors of Th1 cells (54). A more recent study further suggested that CXCR3+ TN-like cells in the CD8+ lineage were young TMEM cells (55). We therefore performed a number of different assays to characterize the naive and memory properties of TNR3 and TNR3+ cells.

The replicative history of T cell populations can be assessed by measuring TRECs, which are progressively diluted upon cell division (56). In ex vivo assays, we found that TRECs were ∼2-fold more common in TNR3 cells compared with TNR3+ cells, ∼4-fold more common in TNR3 cells compared with TSCM cells (9), and ∼25-fold more common in TNR3 cells compared with TMEM cells (Fig. 2A). TNR3+ cells therefore underwent on average one additional round of division in vivo relative to TNR3 cells, suggesting a link between homeostatic proliferation and the acquisition of CXCR3.

FIGURE 2.

FIGURE 2.

True naivety of TNR3+ cells. (A) TREC copies relative to TNR3 cells in CD8+ T cell subsets isolated from PB (TNR3, TNR3+, and TMEM cells, n = 10; TSCM cells, n = 4). Numbers indicate fold change relative to TNR3 cells. Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, ****p < 0.0001 (nonparametric ANOVA with Dunn posttest). (B) Representative flow cytometric analysis showing NV9 (CMV), GL9 (Flu), and EV10 (MART-1) tetramer+ events versus CXCR3 expression among CD8+ T cell subsets in PB. Plots on the top row show CD45ROCCR7+CD27+CD95 TN cells subgated as TNR3, TNR3+, and TMNP cells. (C) Frequency analysis of tetramer+ events as shown in (B) (CMV, n = 6; Flu, n = 7; MART-1, n = 8). Data are shown as mean ± SEM. n.d., not detected. *p < 0.05, **p < 0.01 (nonparametric ANOVA with Dunn posttest). (D) Frequency analysis of Ag-specific CD8+ T cell precursors among TNR3, TNR3+, and TMEM cells. Bars indicate median values. Each dot represents one donor (n = 3).

Truly naive T cell populations lack clonal expansions specific for exogenous Ags, but occasionally harbor large numbers of precursors specific for certain self-derived Ags (57). In line with these predictions, HLA-A*0201–restricted CD8+ T cells specific for immunodominant epitopes derived from CMV and Flu were uncommon in the TNR3 and TNR3+ cell subsets, but abundant in the TSCM and TMEM cell subsets (9), whereas HLA-A*0201–restricted CD8+ T cells specific for an immunodominant epitope derived from MART-1 were common in TNR3 and TNR3+ cell subsets (Fig. 2B, 2C). A recent study identified a rare population of memory cells with a TN-like phenotype (TMNP) that expressed high levels of CD49d and CXCR3 and rapidly produced IFN-γ in response to stimulation with PMA and ionomycin (58). CD8+ T cells specific for epitopes derived from persistent viruses, such as CMV and EBV, but not acute viruses, such as Flu, were detected in the TMNP cell pool (58). In contrast, we detected Flu-specific CD8+ T cells, but not CMV-specific CD8+ T cells, in the TMNP cell subset, which comprised ∼0.5% of the TNR3+ cell population (Fig. 2B, 2C).

Our findings with the MART-1–derived epitope suggested that Ag-specific precursors were not compartmentalized to particular subsets of TN cells. To confirm this inference at the level of exogenous Ags, we screened amplified libraries of TNR3, TNR3+, and TMEM cells with peptide-pulsed APCs (36). Similar frequencies of CD8+ T cells specific for previously unencountered (HIV-1 and Zika virus) and more prevalent viruses (CMV, EBV, and Flu) were detected in the TNR3 and TNR3+ cell pools (Fig. 2D). An exception was noted in one donor, who harbored remarkably high frequencies of HIV-1–specific TNR3 cells, but not HIV-1–specific TNR3+ cells, potentially indicating degenerate recognition by cross-reactive TCRs (59). As expected, CD8+ T cells specific for previously unencountered viruses were largely undetectable in the TMEM cell pool, whereas CD8+ T cells specific for more prevalent viruses were common in the TMEM cell pool (Fig. 2D).

TNR3+ cells are biased toward effector differentiation

In further experiments, we assessed the relationship between TNR3, TNR3+, and TMEM cells at the level of gene expression. Principal component analysis of the entire data set revealed that TNR3 and TNR3+ cells were largely distinct from conventional TMEM cells (Fig. 3A). Paired analysis of samples isolated from individual donors (n = 4) identified 345 genes that were differentially expressed (p < 0.01) between TNR3 and TNR3+ cells (Supplemental Table I). The effector/memory–related transcripts EOMES, MYB, and ANXA1 (60), and the costimulatory receptor CD226, which encodes DNAX accessory molecule-1 (DNAM-1), were preferentially expressed in TNR3+ cells (Fig. 3B). A total of 2567 DEGs, including BHLHE40, a transcription factor associated with effector differentiation, and NT5E, which encodes CD73, a surface enzyme involved in the generation of adenosine, were identified using a less stringent cut-off (p < 0.05; Supplemental Table I). Differential expression of CD73 and CD226 was further confirmed at the protein level via flow cytometry (Supplemental Fig. 1E). In contrast, transcription factors associated with the regulation of thymocyte differentiation, such as RUNX1, SOX4, and IKZF1, were overexpressed in TNR3 cells (Fig. 3B, Supplemental Table I).

FIGURE 3.

FIGURE 3.

TNR3+ cells are biased toward effector differentiation. (A) Principal component analysis based on the expression levels of genes with coefficients of variation larger than the 90th percentile of the coefficients of variation in the entire data set, determined via microarray analysis. Labels indicate donors (n = 4). (B) Heatmap showing DEGs (p < 0.01) in TNR3 versus TNR3+ cells (n = 4). The most relevant genes associated with immune functions are listed. (C) Normalized enrichment score (NES) and FDR for each gene signature enriched in TNR3+ versus TNR3 cells, determined via GSEA. (D) Frequency analysis of cytokine production by TNR3, TNR3+, and TMEM cells after stimulation with PMA and ionomycin (TNR3 and TNR3+, n = 6; TMEM cells, n = 2). Data are shown as mean ± SEM. *p < 0.05, **p < 0.01 (paired t test). Statistics were omitted for comparisons with TMEM cells. (E) Representative flow cytometric analysis of CFSE dilution in TNR3, TNR3+, and TMEM cells after stimulation for 10 d with autologous monocytes presenting epitopes derived from CMV. (F) Frequency analysis of TNR3, TNR3+, and TMEM cells that proliferated (CFSElo) in response to stimulation for 10 d as in (E) (n = 5). Data are shown as mean ± SEM. *p < 0.05 (nonparametric ANOVA). (G) Representative flow cytometric analysis of effector molecules produced by CFSElo TNR3 and CFSElo TNR3+ cells [identified as in (E)] after stimulation with PMA and ionomycin. Numbers indicate the percentage of cells in each gate. (H) Mean summary of data obtained as in (G). Each dot represents a different donor. *p < 0.05, ***p < 0.001 (paired t test).

To capture global trends in gene expression, we performed GSEA. This approach revealed that gene sets involved in the cell cycle, transcriptional activity, and the respiratory electron transport chain (REACTOME Database), as well as transcripts associated with effector and memory activity (Immunological Signatures Database), were strongly enriched in TNR3+ versus TNR3 cells (FDR < 0.001; Fig. 3C). These findings suggested that TNR3+ cells were better poised to differentiate and acquire effector functionality compared with TNR3 cells. To test this hypothesis, we stimulated flow-sorted TNR3, TNR3+, and TMEM cells directly ex vivo with PMA and ionomycin. Twice as many TNR3+ cells produced IL-2, potentially reflecting decreased expression of IKZF1, an inhibitor of IL-2 production in CD8+ TN cells (61), and TNF compared with TNR3 cells (Fig. 3D). In line with their naive status, however, both TNR3 and TNR3+ cells largely failed to produce IFN-γ, unlike TMEM cells (Fig. 3D). The corresponding subsets were also flow-sorted from CMV-seronegative donors and cultured for 10 d with autologous monocytes presenting epitopes derived from CMV. Ag-driven proliferation was observed in the TNR3 and TNR3+ cell subsets, but not in the TMEM cell subset (Fig. 3E, 3F). Importantly, CMV-specific TNR3+ cells that underwent proliferation, assessed via serial dilution of CFSE, produced more IFN-γ and perforin and tended to produce more TNF compared with TNR3 cells after stimulation with PMA and ionomycin on d 10 (Fig. 3G, 3H).

TNR3 and TNR3+ cells express qualitatively distinct TCRs

In mice, enhanced TCR reactivity against self-derived Ags correlates with surface expression of CD5 and determines the efficiency of TN cell recruitment in response to foreign Ags (2022). We found that surface levels of CD5 were comparable between TNR3 and TNR3+ cells (Fig. 4A). However, the strength of TCR interactions with pMHCI molecules can also be inferred from the physicochemical properties of TRB CDR3 sequences (23, 40, 62, 63), as was recently proposed for human and mouse regulatory T cells (6466) and CD4+ T cells (67). We therefore used a high-throughput approach to sequence the TRB repertoires of flow-sorted TNR3, TNR3+, and TMEM cells. Importantly, TNR3 and TNR3+ cells from individual donors exhibited similar patterns of TRBV-TRBJ use (Jenson-Shannon divergence analysis), indicating a close relationship, whereas distinct patterns of TRBV-TRBJ use were observed in the corresponding TMEM cell subsets (Fig. 4B). Repertoire diversity was comparably high in the TNR3 and TNR3+ cell subsets, as expected for truly naive populations, but much lower in the corresponding TMEM cell subsets, quantified using normalized Shannon-Weiner and Chao1 metrics (Fig. 4C, 4D). We then determined the averaged physicochemical properties of the 5 aa residues located in the middle of each TRB CDR3 sequence, which dominate interface contacts with the peptide component of pMHCI molecules (62). At the population level, increased hydrophobicity (lower Kidera factor 4), lower energy (40, 63), and higher strength and volume indices, calculated using VDJtools (39), were observed for TRB CDR3 sequences in the TNR3+ cell pool compared with TRB CDR3 sequences in the TNR3 cell pool (Fig. 4E).

FIGURE 4.

FIGURE 4.

TNR3 and TNR3+ cells express qualitatively distinct TCRs. (A) Representative flow cytometric analysis of CD5 expression on the surface of human TNR3, TNR3+, and TMEM cells. Similar data were obtained from three other donors. (B) Cluster analysis of TRBV-TRBJ use among TNR3, TNR3+, and TMEM cells (TNR3 and TNR3+, n = 5; TMEM cells, n = 3). (C) Normalized Shannon-Wiener diversity index and (D) Chao1 diversity index calculated for 5000 unique UMI-labeled TRB CDR3 molecules from two independent experiments (n = 11). ***p < 0.001 (Tukey range test). (E) Averaged (weighted per clonal size) Kidera factor 4 (KF4), Miyazawa-Jernigan energy (MJenergy), strength, and volume indices for the 5 aa residues located the middle of the TRB CDR3 sequences extracted from the TNR3 and TNR3+ cell repertoires [details as in (D)]. **p < 0.01, ***p < 0.001, ****p < 0.0001 (paired t test).

TNR3+ cells are transcriptionally equivalent in humans and mice

To corroborate these findings, which suggested that TCRs with higher intrinsic affinities for self-derived Ags were more prevalent in the TNR3+ cell pool compared with the TNR3 cell pool, we extended our analysis to the murine CD8+ TN compartment (defined as CD44loCD62Lhi). Murine TNR3+ cells were contained almost exclusively within the CD5hi fraction (Fig. 5A, 5B). These cells were shown previously to respond more vigorously to foreign Ags compared with CD5lo and CD5hi TN cells (22). To characterize murine TNR3+ cells in more detail, we flow-sorted CD5loCXCR3 (CD5lo), CD5hiCXCR3 (CD5hi), and CD5hiCXCR3+ (TNR3+) cells from the splenic CD44loCD62Lhi TN cell pool, together with CD44hi TMEM cells, and defined the transcriptional profile of each subset using RNAseq. All three TN cell subsets were clearly distinct at the transcriptional level compared with the conventional TMEM cell subset, based on the biological coefficient of variation (Fig. 5C). However, we also identified 636 DEGs (FDR < 0.001) among the TN cell subsets (Fig. 5D, Supplemental Table II). In addition to Cd5 and Cxcr3, murine TNR3+ cells overexpressed genes associated with effector differentiation, including Tbx21, Ccl5, Irf8, Hopx, Junb, Fos, and Jun (Fig. 5D, Supplemental Table II), and with less stringent criteria (FDR < 0.05), underexpressed genes associated with a naive phenotype, including Lef1 and Ccr7, compared with both CD5lo and CD5hi TN cells (Supplemental Table II). Importantly, DEGs identified in the corresponding human TN cell subsets, such as Ccr9, Eomes, Nt5e, Myb, Sox4, and Ikzf1, were also differentially expressed among murine TN cell subsets (Fig. 5D, Supplemental Table II). In accordance with these data, genes upregulated in murine TNR3+ versus CD5lo (n = 221; FDR < 0.0001) and murine TNR3+ versus CD5hi cells (n = 37; FDR < 0.0001) were also preferentially enriched in human TNR3+ versus TNR3 cells, indicating close transcriptional parallels between TNR3+ cells in different species (Figs. 3C, 5E).

FIGURE 5.

FIGURE 5.

TNR3+ cells are transcriptionally equivalent in humans and mice. (A) Left: representative flow cytometric analysis of CD5 and CXCR3 expression on the surface of murine CD8+ TN cells (CD44loCD62Lhi). Right: postsort purity analysis of murine CD5lo, CD5hi, and TNR3+ cells. (B) Mean fluorescence intensity (MFI) of CD5 expression on the surface of murine TNR3 and TNR3+ cells, gated as CD44loCD62LhiCXCR3 and CD44loCD62LhiCXCR3+, respectively (n = 5). ****p < 0.0001 (paired t test). (C) Biological coefficient of variation (BCV) plot derived from RNAseq profiles of murine CD5lo, CD5hi, and TNR3+ cells isolated as in (A) (n = 5). Bulk memory CD8+ T cells are shown as CD44hi (n = 3). (D) Heatmap showing DEGs (FDR < 0.0001) among CD5lo, CD5hi, and TNR3+ cells isolated as in (A). The most relevant genes associated with immune functions are listed. (E) GSEA plots showing murine TNR3+ versus CD5hi (top) and murine TNR3+ versus CD5lo gene sets (bottom) that were significantly enriched in human TNR3+ versus TNR3 cells (Fig. 3C).

Discussion

It has become apparent in recent years that the classically defined TN cell pool incorporates subpopulations of cells with memory-like properties, including TSCM cells (9, 51) and TMNP cells (58). In this study, we found that truly naive T cells can also exhibit distinct characteristics, both in humans and in mice. Specifically, we identified two discrete subsets of CD8+ TN cells in each species, defined by the absence or presence of the chemokine receptor CXCR3. In humans, TNR3+ cells more frequently produced IL-2 and TNF in response to nonspecific activation directly ex vivo, differentiated more readily to acquire various effector functions in vitro after stimulation with cognate Ag, and overexpressed a distinct array of genes compared with TNR3 cells. Repertoire analysis further indicated that TNR3+ cells expressed TCRs with enhanced Ag sensitivity, despite comparably high levels of diversity in the TNR3 and TNR3+ cell pools. Moreover, human TNR3+ cells were phenotypically and transcriptionally equivalent to murine TNR3+ cells, which expressed high levels of CD5. It is notable in this regard that CXCR3 has also been shown to demarcate functionally superior CD8+ T cells that respond to innate signals in the murine CD44hi memory compartment (68, 69).

In mice, the ability of CD8+ TN cells to respond to infectious agents has been shown to correlate with TCR sensitivity for self-derived Ags (22), which can be assessed by measuring surface expression of CD5 (2023). Accordingly, genes associated with the cell cycle and effector differentiation, including Tbx21 and Eomes, were upregulated in CD5hi TN cells compared with CD5lo TN cells (22). Some murine CD5hi TN cells also expressed CXCR3 (22). We found that these murine TNR3+ cells overexpressed several transcripts associated with effector differentiation compared with both CD5lo and CD5hi cells, closely mirroring the transcriptional identity of human TNR3+ cells. It remains unclear to what extent CD5 can be used to identify functionally distinct subsets of human TN cells (24, 25). However, TN cells with a proclivity for effector differentiation were clearly defined in our data set on the basis of CXCR3 expression, thereby providing a unique identifier for the isolation of truly naive precursors with functional properties that may be useful in the context of various immunotherapies.

Recent data have shown that memory-like CD8+ T cells are retained in the skin and thymus of nonimmunized mice via a CXCR3-dependent mechanism (70). We found that TNR3+ cells were virtually excluded from mucosal sites, including the skin, but were relatively abundant in PB and LNs. It also seems likely that TNR3 and TNR3+ cells recirculate continuously between these latter two compartments, because neither subset expressed the tissue-residency markers CD69 and CD103. In line with these findings, another study reported that CXCR3-dependent signaling was undetectable in naive and memory CD8+ T cells directly ex vivo, but increased with stimulation via the TCR (71). Moreover, the CXCR3 ligands CXCL9, CXCL10, and CXCL11 are poorly expressed at steady-state and only become upregulated in the context of inflammation (72, 73). The functional and migratory advantages of TNR3+ cells relative to TNR3 cells may therefore be confined to the setting of immune activation, as described previously for murine CXCR3+ TCM cells, which localize rapidly to peripheral areas of the relevant LNs in response to challenge with previously encountered Ags (73).

TRECs were modestly diluted in TNR3+ cells compared with TNR3 cells, indicating a slightly higher rate of homeostatic turnover in vivo, akin to that observed previously for CD5hi TN cells compared with CD5lo TN cells in lymphopenic mice (23). Homeostatic proliferation may even drive the acquisition of CXCR3 (74). In this scenario, TNR3+ cells would arise as a natural consequence of enhanced tonic signaling via qualitatively distinct TCRs with a predilection for self-derived Ags. Alternatively, TNR3+ cells may be preprogrammed during thymic development to respond more vigorously to homeostatic signals in the periphery. In line with this possibility, a recent study demonstrated that murine TN cells generated early in life, which resembled TNR3+ cells at the transcriptional level, were more prone to effector differentiation than murine TN cells generated later in life (75).

In summary, we have shown that humans and mice harbor at least two distinct subsets of TN cells, defined by the absence or presence of CXCR3. The greater effector differentiation potential of TNR3+ cells bestows obvious kinetic advantages, enabling timely immune responses in the face of perceived threats to the host (22). The biological role of TNR3 cells is less clear. A parallel repertoire of qualitatively distinct TCRs may nonetheless be required to cover any potential “holes” in the spectrum of adaptive immune specificities, even at the cost of a selection disadvantage in the overall TN cell pool (76). On this basis, we propose that the preimmune repertoire is organized into functionally and transcriptionally discrete subsets, which fulfill different roles in the immune system, collectively ensuring balanced and comprehensive effector responses to exogenous Ags.

Supplementary Material

Data Supplement
JI_1901072.zip (3.6MB, zip)

Acknowledgments

We thank Gioacchino Natoli, Sara Polletti, and Javier Cibella (Humanitas Research Hospital, Italy) for assistance with RNAseq library preparation, Daniel Douek (National Institutes of Health), Andrea Cossarizza, and Marcello Pinti (University of Modena, Italy) for assistance with the TREC assay, David Jarrossay (Institute for Research in Biomedicine, Italy) for cell sorting, Giovanni Colombo and Giovanni Cugini (Humanitas Research Hospital, Italy) for the provision of human LNs, Rafi Ahmed (Emory University), Stephen Jameson (University of Minnesota), and members of the Laboratory of Translational Immunology (Humanitas Research Hospital, Italy) for helpful discussions, and Alessandro Sette (La Jolla Institute for Immunology) for the kind gift of peptide pools corresponding to immunogenic regions of CMV and EBV.

This work was supported by the European Research Council (ERC_StG_2014 PERSYST 640511 to E.L.), the Italian Ministry of Health Giovani Ricercatori Program (GR-2011-02347324 to E.L.), the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (to J.M.F.), the Swiss National Science Foundation (149475 to F.S.), and the Humanitas Clinical and Research Center (to E.L.). G.D.S. was the recipient of an Armanda ed Enrico Mirto Fellowship from the Fondazione Italiana per la Ricerca sul Cancro-Associazione Italiana per la Ricerca sul Cancro (FIRC-AIRC). A.N.D. and M.M. were supported by the Ministry of Education, Youth, and Sports of the Czech Republic under project CEI TEC 2020 LQ1601. M.K. was supported by a grant from the Italian Ministry of Education (SIR-RBSI14BAO5). E.S. was the recipient of a FIRC-AIRC Fellowship. D.A.P. was supported by a Wellcome Trust Senior Investigator Award (100326/Z/12/Z). M.I. was supported by grants from the Italian Association for Cancer Research (19891), the Italian Ministry of Health (GR-2011-02347925), the Lombardy Foundation for Biomedical Research (2015-0010), and the European Molecular Biology Organization Young Investigator Program, and was the recipient of a Career Development Award from the Giovanni Armenise–Harvard Foundation and a Consolidator Grant from the European Research Council (725038). D.M.C. was supported by a grant to create the Center for High-Precision Editing and Genetic Technologies for Biomedicine from the Ministry of Science and Higher Education of the Russian Federation. F.S. and the Institute for Research in Biomedicine were supported by the Helmut Horten Foundation. The purchase of a FACS Symphony A5 was defrayed in part by a grant from the Italian Ministry of Health (Agreement 82/2015).

The sequences presented in this article have been submitted to the Gene Expression Omnibus under accession number GSE125102 and to the ArrayExpress Database under accession number E-MTAB-7638.

The online version of this article contains supplemental material.

Abbreviations used in this article:
Ct
cycle threshold
CyTOF
cytometry by time-of-flight
DEG
differentially expressed gene
FDR
false discovery rate
Flu
influenza virus, GSEA, gene set enrichment analysis
LN
lymph node
M1
matrix protein 1
pMHC
peptide–MHC class I
qPCR
quantitative PCR
RNAseq
RNA sequencing
TMEM
memory T
TMNP
memory cell with a TN-like phenotype
TN
naive T
TREC
TCR rearrangement excision circle
TSCM
stem cell–like TMEM
tSNE
t-distributed stochastic neighbor embedding
UMI
unique molecular identifier.

Disclosures

In work at the Laboratory of Translational Immunology, E.L. receives reagents in kind as part of a collaborative research agreement with BD Biosciences (Italy). The other authors have no conflicts of interest to disclose.

References

  • 1.Qi Q., Liu Y., Cheng Y., Glanville J., Zhang D., Lee J. Y., Olshen R. A., Weyand C. M., Boyd S. D., Goronzy J. J. 2014. Diversity and clonal selection in the human T-cell repertoire. Proc. Natl. Acad. Sci. USA 111: 13139–13144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Britanova O. V., Shugay M., Merzlyak E. M., Staroverov D. B., Putintseva E. V., Turchaninova M. A., Mamedov I. Z., Pogorelyy M. V., Bolotin D. A., Izraelson M., et al. 2016. Dynamics of individual T cell repertoires: from cord blood to centenarians. J. Immunol. 196: 5005–5013. [DOI] [PubMed] [Google Scholar]
  • 3.Wooldridge L., Ekeruche-Makinde J., van den Berg H. A., Skowera A., Miles J. J., Tan M. P., Dolton G., Clement M., Llewellyn-Lacey S., Price D. A., et al. 2012. A single autoimmune T cell receptor recognizes more than a million different peptides. J. Biol. Chem. 287: 1168–1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hogquist K. A., Jameson S. C. 2014. The self-obsession of T cells: how TCR signaling thresholds affect fate ‘decisions’ and effector function. Nat. Immunol. 15: 815–823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Murali-Krishna K., Lau L. L., Sambhara S., Lemonnier F., Altman J., Ahmed R. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286: 1377–1381. [DOI] [PubMed] [Google Scholar]
  • 6.Sprent J., Cho J. H., Boyman O., Surh C. D. 2008. T cell homeostasis. Immunol. Cell Biol. 86: 312–319. [DOI] [PubMed] [Google Scholar]
  • 7.Kaech S. M., Tan J. T., Wherry E. J., Konieczny B. T., Surh C. D., Ahmed R. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191–1198. [DOI] [PubMed] [Google Scholar]
  • 8.Sallusto F., Geginat J., Lanzavecchia A. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745–763. [DOI] [PubMed] [Google Scholar]
  • 9.Gattinoni L., Lugli E., Ji Y., Pos Z., Paulos C. M., Quigley M. F., Almeida J. R., Gostick E., Yu Z., Carpenito C., et al. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17: 1290–1297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Henning A. N., Roychoudhuri R., Restifo N. P. 2018. Epigenetic control of CD8+ T cell differentiation. Nat. Rev. Immunol. 18: 340–356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mahnke Y. D., Brodie T. M., Sallusto F., Roederer M., Lugli E. 2013. The who’s who of T-cell differentiation: human memory T-cell subsets. Eur. J. Immunol. 43: 2797–2809. [DOI] [PubMed] [Google Scholar]
  • 12.Henson S. M., Lanna A., Riddell N. E., Franzese O., Macaulay R., Griffiths S. J., Puleston D. J., Watson A. S., Simon A. K., Tooze S. A., Akbar A. N. 2014. p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells. J. Clin. Invest. 124: 4004–4016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bantug G. R., Galluzzi L., Kroemer G., Hess C. 2018. The spectrum of T cell metabolism in health and disease. Nat. Rev. Immunol. 18: 19–34. [DOI] [PubMed] [Google Scholar]
  • 14.Kaech S. M., Ahmed R. 2001. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells. Nat. Immunol. 2: 415–422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Stemberger C., Huster K. M., Koffler M., Anderl F., Schiemann M., Wagner H., Busch D. H. 2007. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity 27: 985–997. [DOI] [PubMed] [Google Scholar]
  • 16.van den Broek T., Borghans J. A. M., van Wijk F. 2018. The full spectrum of human naive T cells. Nat. Rev. Immunol. 18: 363–373. [DOI] [PubMed] [Google Scholar]
  • 17.Buchholz V. R., Flossdorf M., Hensel I., Kretschmer L., Weissbrich B., Gräf P., Verschoor A., Schiemann M., Höfer T., Busch D. H. 2013. Disparate individual fates compose robust CD8+ T cell immunity. Science 340: 630–635. [DOI] [PubMed] [Google Scholar]
  • 18.Gerlach C., Rohr J. C., Perié L., van Rooij N., van Heijst J. W., Velds A., Urbanus J., Naik S. H., Jacobs H., Beltman J. B., et al. 2013. Heterogeneous differentiation patterns of individual CD8+ T cells. Science 340: 635–639. [DOI] [PubMed] [Google Scholar]
  • 19.Tubo N. J., Pagán A. J., Taylor J. J., Nelson R. W., Linehan J. L., Ertelt J. M., Huseby E. S., Way S. S., Jenkins M. K. 2013. Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell 153: 785–796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mandl J. N., Monteiro J. P., Vrisekoop N., Germain R. N. 2013. T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens. Immunity 38: 263–274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Persaud S. P., Parker C. R., Lo W. L., Weber K. S., Allen P. M. 2014. Intrinsic CD4+ T cell sensitivity and response to a pathogen are set and sustained by avidity for thymic and peripheral complexes of self peptide and MHC. Nat. Immunol. 15: 266–274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fulton R. B., Hamilton S. E., Xing Y., Best J. A., Goldrath A. W., Hogquist K. A., Jameson S. C. 2015. The TCR’s sensitivity to self peptide-MHC dictates the ability of naive CD8(+) T cells to respond to foreign antigens. Nat. Immunol. 16: 107–117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Cho J. H., Kim H. O., Surh C. D., Sprent J. 2010. T cell receptor-dependent regulation of lipid rafts controls naive CD8+ T cell homeostasis. Immunity 32: 214–226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Alanio C., Nicoli F., Sultanik P., Flecken T., Perot B., Duffy D., Bianchi E., Lim A., Clave E., van Buuren M. M., et al. 2015. Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients. eLife. DOI: 10.7554/eLife.07916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yu W., Jiang N., Ebert P. J., Kidd B. A., Müller S., Lund P. J., Juang J., Adachi K., Tse T., Birnbaum M. E., et al. 2015. Clonal deletion prunes but does not eliminate self-specific αβ CD8+ T lymphocytes. Immunity 42: 929–941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lugli E., Mueller Y. M., Lewis M. G., Villinger F., Katsikis P. D., Roederer M. 2011. IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. Blood 118: 2520–2529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wong M. T., Ong D. E., Lim F. S., Teng K. W., McGovern N., Narayanan S., Ho W. Q., Cerny D., Tan H. K., Anicete R., et al. 2016. A high-dimensional atlas of human T cell diversity reveals tissue-specific trafficking and cytokine signatures. Immunity 45: 442–456. [DOI] [PubMed] [Google Scholar]
  • 28.Cossarizza A., Chang H. D., Radbruch A., Akdis M., Andrä I., Annunziato F., Bacher P., Barnaba V., Battistini L., Bauer W. M., et al. 2017. Guidelines for the use of flow cytometry and cell sorting in immunological studies. Eur. J. Immunol. 47: 1584–1797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Brummelman J., Haftmann C., Núñez N. G., Alvisi G., Mazza E. M. C., Becher B., Lugli E. 2019. Development, application and computational analysis of high-dimensional fluorescent antibody panels for single-cell flow cytometry. Nat. Protoc. 14: 1946–1969. [DOI] [PubMed] [Google Scholar]
  • 30.Brummelman J., Mazza E. M. C., Alvisi G., Colombo F. S., Grilli A., Mikulak J., Mavilio D., Alloisio M., Ferrari F., Lopci E., et al. 2018. High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors. J. Exp. Med. 215: 2520–2535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Pilia G., Chen W. M., Scuteri A., Orrú M., Albai G., Dei M., Lai S., Usala G., Lai M., Loi P., et al. 2006. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2: e132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Orrù V., Steri M., Sole G., Sidore C., Virdis F., Dei M., Lai S., Zoledziewska M., Busonero F., Mulas A., et al. 2013. Genetic variants regulating immune cell levels in health and disease. Cell 155: 242–256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Douek D. C., McFarland R. D., Keiser P. H., Gage E. A., Massey J. M., Haynes B. F., Polis M. A., Haase A. T., Feinberg M. B., Sullivan J. L., et al. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690–695. [DOI] [PubMed] [Google Scholar]
  • 34.Price D. A., Brenchley J. M., Ruff L. E., Betts M. R., Hill B. J., Roederer M., Koup R. A., Migueles S. A., Gostick E., Wooldridge L., et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349–1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Roberto A., Castagna L., Zanon V., Bramanti S., Crocchiolo R., McLaren J. E., Gandolfi S., Tentorio P., Sarina B., Timofeeva I., et al. 2015. Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation. Blood 125: 2855–2864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Geiger R., Duhen T., Lanzavecchia A., Sallusto F. 2009. Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J. Exp. Med. 206: 1525–1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Shugay M., Britanova O. V., Merzlyak E. M., Turchaninova M. A., Mamedov I. Z., Tuganbaev T. R., Bolotin D. A., Staroverov D. B., Putintseva E. V., Plevova K., et al. 2014. Towards error-free profiling of immune repertoires. Nat. Methods 11: 653–655. [DOI] [PubMed] [Google Scholar]
  • 38.Bolotin D. A., Poslavsky S., Mitrophanov I., Shugay M., Mamedov I. Z., Putintseva E. V., Chudakov D. M. 2015. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12: 380–381. [DOI] [PubMed] [Google Scholar]
  • 39.Shugay M., Bagaev D. V., Turchaninova M. A., Bolotin D. A., Britanova O. V., Putintseva E. V., Pogorelyy M. V., Nazarov V. I., Zvyagin I. V., Kirgizova V. I., et al. 2015. VDJtools: unifying post-analysis of T cell receptor repertoires. PLoS Comput. Biol. 11: e1004503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Miyazawa S., Jernigan R. L. 1996. Residue-residue potentials with a favorable contact pair term and an unfavorable high packing density term, for simulation and threading. J. Mol. Biol. 256: 623–644. [DOI] [PubMed] [Google Scholar]
  • 41.Kidera A., Konishi Y., Oka M., Ooi T., Scheraga H. A. 1985. Statistical analysis of the physical properties of the 20 naturally occurring amino acids. J. Protein Chem. 4: 23–55. [Google Scholar]
  • 42.Rackovsky S. 2010. Global characteristics of protein sequences and their implications. Proc. Natl. Acad. Sci. USA 107: 8623–8626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Roberto A., Di Vito C., Zaghi E., Mazza E. M. C., Capucetti A., Calvi M., Tentorio P., Zanon V., Sarina B., Mariotti J., et al. 2018. The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation. Haematologica 103: 1390–1402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Irizarry R. A., Hobbs B., Collin F., Beazer-Barclay Y. D., Antonellis K. J., Scherf U., Speed T. P. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249–264. [DOI] [PubMed] [Google Scholar]
  • 45.Ritchie M. E., Phipson B., Wu D., Hu Y., Law C. W., Shi W., Smyth G. K. 2015. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43: e47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Dobin A., Davis C. A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T. R. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29: 15–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Robinson M. D., McCarthy D. J., Smyth G. K. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139–140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.De Rosa S. C., Herzenberg L. A., Herzenberg L. A., Roederer M. 2001. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med. 7: 245–248. [DOI] [PubMed] [Google Scholar]
  • 49.Lugli E., Gattinoni L., Roberto A., Mavilio D., Price D. A., Restifo N. P., Roederer M. 2013. Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat. Protoc. 8: 33–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Brodie T., Brenna E., Sallusto F. 2013. OMIP-018: chemokine receptor expression on human T helper cells. [Published erratum appears in 2013 Cytometry A 83: 1041–1045.] Cytometry A 83: 530–532. [DOI] [PubMed] [Google Scholar]
  • 51.Lugli E., Dominguez M. H., Gattinoni L., Chattopadhyay P. K., Bolton D. L., Song K., Klatt N. R., Brenchley J. M., Vaccari M., Gostick E., et al. 2013. Superior T memory stem cell persistence supports long-lived T cell memory. J. Clin. Invest. 123: 594–599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Thome J. J., Yudanin N., Ohmura Y., Kubota M., Grinshpun B., Sathaliyawala T., Kato T., Lerner H., Shen Y., Farber D. L. 2014. Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 159: 814–828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Cossarizza A., Ortolani C., Paganelli R., Barbieri D., Monti D., Sansoni P., Fagiolo U., Castellani G., Bersani F., Londei M., Franceschi C. 1996. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech. Ageing Dev. 86: 173–195. [DOI] [PubMed] [Google Scholar]
  • 54.Song K., Rabin R. L., Hill B. J., De Rosa S. C., Perfetto S. P., Zhang H. H., Foley J. F., Reiner J. S., Liu J., Mattapallil J. J., et al. 2005. Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans. Proc. Natl. Acad. Sci. USA 102: 7916–7921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Murata K., Tsukahara T., Emori M., Shibayama Y., Mizushima E., Matsumiya H., Yamashita K., Kaya M., Hirohashi Y., Kanaseki T., et al. 2016. Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance. OncoImmunology 5: e1165376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.McFarland R. D., Douek D. C., Koup R. A., Picker L. J. 2000. Identification of a human recent thymic emigrant phenotype. Proc. Natl. Acad. Sci. USA 97: 4215–4220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Pittet M. J., Valmori D., Dunbar P. R., Speiser D. E., Liénard D., Lejeune F., Fleischhauer K., Cerundolo V., Cerottini J. C., Romero P. 1999. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J. Exp. Med. 190: 705–715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Pulko V., Davies J. S., Martinez C., Lanteri M. C., Busch M. P., Diamond M. S., Knox K., Bush E. C., Sims P. A., Sinari S., et al. 2016. Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses. Nat. Immunol. 17: 966–975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Campion S. L., Brodie T. M., Fischer W., Korber B. T., Rossetti A., Goonetilleke N., McMichael A. J., Sallusto F. 2014. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J. Exp. Med. 211: 1273–1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Pilipow K., Scamardella E., Puccio S., Gautam S., De Paoli F., Mazza E. M., De Simone G., Polletti S., Buccilli M., Zanon V., et al. 2018. Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity. JCI Insight 3: e122299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.O’Brien S., Thomas R. M., Wertheim G. B., Zhang F., Shen H., Wells A. D. 2014. Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production. J. Immunol. 192: 5118–5129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Egorov E. S., Kasatskaya S. A., Zubov V. N., Izraelson M., Nakonechnaya T. O., Staroverov D. B., Angius A., Cucca F., Mamedov I. Z., Rosati E., et al. 2018. The changing landscape of naive T cell receptor repertoire with human aging. Front. Immunol. 9: 1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kosmrlj A., Jha A. K., Huseby E. S., Kardar M., Chakraborty A. K. 2008. How the thymus designs antigen-specific and self-tolerant T cell receptor sequences. Proc. Natl. Acad. Sci. USA 105: 16671–16676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Feng Y., van der Veeken J., Shugay M., Putintseva E. V., Osmanbeyoglu H. U., Dikiy S., Hoyos B. E., Moltedo B., Hemmers S., Treuting P., et al. 2015. A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance. Nature 528: 132–136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Bolotin D. A., Poslavsky S., Davydov A. N., Frenkel F. E., Fanchi L., Zolotareva O. I., Hemmers S., Putintseva E. V., Obraztsova A. S., Shugay M., et al. 2017. Antigen receptor repertoire profiling from RNA-seq data. Nat. Biotechnol. 35: 908–911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Izraelson M., Nakonechnaya T. O., Moltedo B., Egorov E. S., Kasatskaya S. A., Putintseva E. V., Mamedov I. Z., Staroverov D. B., Shemiakina I. I., Zakharova M. Y., et al. 2018. Comparative analysis of murine T-cell receptor repertoires. Immunology 153: 133–144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Stadinski B. D., Shekhar K., Gómez-Touriño I., Jung J., Sasaki K., Sewell A. K., Peakman M., Chakraborty A. K., Huseby E. S. 2016. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat. Immunol. 17: 946–955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Oghumu S., Dong R., Varikuti S., Shawler T., Kampfrath T., Terrazas C. A., Lezama-Davila C., Ahmer B. M., Whitacre C. C., Rajagopalan S., et al. 2013. Distinct populations of innate CD8+ T cells revealed in a CXCR3 reporter mouse. J. Immunol. 190: 2229–2240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Oghumu S., Terrazas C. A., Varikuti S., Kimble J., Vadia S., Yu L., Seveau S., Satoskar A. R. 2015. CXCR3 expression defines a novel subset of innate CD8+ T cells that enhance immunity against bacterial infection and cancer upon stimulation with IL-15. FASEB J. 29: 1019–1028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Alanio C., Barreira da Silva R., Michonneau D., Bousso P., Ingersoll M. A., Albert M. L. 2018. CXCR3/CXCL10 axis shapes tissue distribution of memory phenotype CD8+ T cells in nonimmunized mice. J. Immunol. 200: 139–146. [DOI] [PubMed] [Google Scholar]
  • 71.Rabin R. L., Park M. K., Liao F., Swofford R., Stephany D., Farber J. M. 1999. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J. Immunol. 162: 3840–3850. [PubMed] [Google Scholar]
  • 72.Groom J. R., Luster A. D. 2011. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89: 207–215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Sung J. H., Zhang H., Moseman E. A., Alvarez D., Iannacone M., Henrickson S. E., de la Torre J. C., Groom J. R., Luster A. D., von Andrian U. H. 2012. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 150: 1249–1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Kato A., Takaori-Kondo A., Minato N., Hamazaki Y. 2018. CXCR3high CD8+ T cells with naïve phenotype and high capacity for IFN-γ production are generated during homeostatic T-cell proliferation. Eur. J. Immunol. 48: 1663–1678. [DOI] [PubMed] [Google Scholar]
  • 75.Smith N. L., Patel R. K., Reynaldi A., Grenier J. K., Wang J., Watson N. B., Nzingha K., Yee Mon K. J., Peng S. A., Grimson A., et al. 2018. Developmental origin governs CD8+ T cell fate decisions during infection. Cell 174: 117–130.e14. [DOI] [PubMed] [Google Scholar]
  • 76.Ogasawara K., Maloy W. L., Schwartz R. H. 1987. Failure to find holes in the T-cell repertoire. Nature 325: 450–452. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Supplement
JI_1901072.zip (3.6MB, zip)

Data Availability Statement

Raw microarray and RNAseq data are available via the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) under accession number GSE125102. Demultiplexed fastq TCR sequencing data are available via the ArrayExpress Database at The European Molecular Biology Laboratory–European Bioinformatics Institute (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-7638.


Articles from The Journal of Immunology Author Choice are provided here courtesy of Oxford University Press

RESOURCES